Home/Filings/4/0001104659-25-021733
4//SEC Filing

MCHUGH THOMAS S 4

Accession 0001104659-25-021733

CIK 0001012477other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:07 PM ET

Size

7.4 KB

Accession

0001104659-25-021733

Insider Transaction Report

Form 4
Period: 2025-03-05
MCHUGH THOMAS S
Chief Financial Officer
Transactions
  • Award

    Ordinary Shares

    2025-03-05+12,600100,400 total
  • Award

    Stock Option (Right to Buy)

    2025-03-05+72,00072,000 total
    Exercise: $7.87Exp: 2030-03-06Ordinary Shares (72,000 underlying)
Footnotes (2)
  • [F1]Consists of a restricted share award. The restricted share award shall vest in equal annual installments on each of the first four anniversaries following the 3/5/2025 grant date.
  • [F2]The options shall vest, if at all, in four equal increments if the volume-weighted average price of the Issuer's Ordinary Shares during any 30 calendar day period exceeds $11, $14, $17 and $19.09, respectively.

Issuer

AVADEL PHARMACEUTICALS PLC

CIK 0001012477

Entity typeother

Related Parties

1
  • filerCIK 0001240547

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:07 PM ET
Size
7.4 KB